Tenascin-C and Matrix Metalloproteinase-9 Levels in Crevicular Fluid of Teeth and Implants

Clinical Implant Dentistry and Related Research

Volumn 14, Issue 5, 2012, Pages 672-681

  Özçakir Tomruk, Ceyda ^a,b   Chiquet, Matthias ^a   Mericske Stern, Regina ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b YEDITEPE UNIVERSITY   (Turkey)

Author keywords

Dental implants; Gingival crevicular fluid; MMP 9; Tenascin C

Indexed keywords

GELATINASE B; SERUM ALBUMIN; TENASCIN;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CHEMISTRY; ENZYMOLOGY; GINGIVITIS; HUMAN; METABOLISM; MIDDLE AGED; NONPARAMETRIC TEST; PERIIMPLANTITIS; REGRESSION ANALYSIS; TOOTH IMPLANT;

ADULT; AGED; CASE-CONTROL STUDIES; DENTAL IMPLANTS; GINGIVAL CREVICULAR FLUID; HUMANS; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PERI-IMPLANTITIS; REGRESSION ANALYSIS; SERUM ALBUMIN; STATISTICS, NONPARAMETRIC; TENASCIN;

EID: 84867099985     PISSN: 15230899     EISSN: 17088208     Source Type: Journal    
DOI: 10.1111/j.1708-8208.2010.00319.x     Document Type: Article

References (36)

1. Esposito M, Thomsen P, Molne J, Gretzer C, Ericson LE, Lekholm U. Immunohistochemistry of soft tissues surrounding late failures of Branemark implants. Clin Oral Implants Res 1997; 8:352-366.
2. Esposito M, Hirsch JM, Lekholm U, Thomsen P. Biological factors contributing to failures of osseointegrated oral implants.(II). Etiopathogenesis. Eur J Oral Sci 1998; 106:721-764.
3. Salvi GE, Lang NP. Diagnostic parameters for monitoring periimplant conditions. Int J Oral Maxillofac Implants 2004; 19 (Suppl):116-127.
4. Mombelli A, Lang NP. Clinical parameters for the evaluation of dental implants. Periodontol 2000 1994; 4:81-86.
5. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001; 17:463-416.
6. Sela J, Gross UM, Kohavi D, etal. Primary mineralization at the surfaces of implants. Crit Rev Oral Biol Med 2000; 11:423-436.
7. Okada Y, Naka K, Kawamura K, etal. Localization of matrix metalloproteinase-9 (92-kilodalton gelatinase/type IV collagenase = gelatinase B) in osteoclasts: implications for bone resorption. Lab Invest 1995; 72:311-322.
8. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 1999; 20:345-357.
9. Hill PA, Docherty AJ, Bottomley KM, etal. Inhibition of bone resorption in vitro by selective inhibitors of gelatinase and collagenase. Biochem J 1995; 308:167-175.
10. Blavier L, Delaisse JM. Matrix metalloproteinases are obligatory for the migration of preosteoclasts to the developing marrow cavity of primitive long bones. J Cell Sci 1995; 108:3649-3659.
11. Everts V, Korper W, Jansen DC, etal. Functional heterogeneity of osteoclasts: matrix metalloproteinases participate in osteoclastic resorption of calvarial bone but not in resorption of long bone. FASEB J 1999; 3:1219-1230.
12. Birkedal-Hansen H. Role of matrix metalloproteinases in human periodontal diseases. J Periodontol 1993; 64:474-484.
13. Chiquet-Ehrismann R, Chiquet M. Tenascins: regulation and putative functions during pathological stress. J Pathol 2003; 200:488-499.
14. Thesleff I, Mackie E, Vainio S, Chiquet-Ehrismann R. Changes in the distribution of tenascin during tooth development. Development 1987; 101:289-296.
15. Matias MA, Li H, Young WG, Bartold PM. Immunohistochemical localisation of extracellular matrix proteins in the periodontium during cementogenesis in the rat molar. Arch Oral Biol 2003; 48:709-716.
16. Lukinmaa PL, Mackie EJ, Thesleff I. Immunohistochemical localization of the Matrix glycoproteins - tenascin and the ED-sequence-containing form of cellular fibronectin - in human permanent teeth and periodontal ligament. J Dent Res 1991; 70:19-26.
17. Zhang X, Schuppan D, Becker J, Reichart P, Gelderblom HR. Distribution of undulin, tenascin, and fibronectin in the human periodontal ligament and cementum: comparative immunoelectron microscopy with ultra-thin cryosections. J Histochem Cytochem 1993; 41:245-251.
18. Sarasa-Renedo A, Chiquet M. Mechanical signals regulating extracellular matrix gene expression in fibroblasts. Scand J Med Sci Sports 2005; 15:223-230.
19. Fraser HS, Palmer RM, Wilson RF, Coward PY, Scott DA. Elevated systemic concentrations of soluble ICAM-1 (sICAM-1) are not reflected in the gingival crevicular fluid of smokers with periodontitis. J Dent Res 2001; 80:1643-1647.
20. Giannopoulou C, Di Felice R, Andersen E, Cimasoni G. Synthesis of alpha 2 macroglobulin in human gingiva: a study of the concentration of macroglobulin and albumin in gingival fluid and serum. Arch Oral Biol 1990; 35:13-16.
21. Pisano E, Cabras T, Montaldo C, etal. Peptides of human gingival crevicular fluid determined by HPLC-ESI-MS. Eur J Oral Sci 2005; 113:462-468.
22. Trachslin J, Koch M, Chiquet M. Rapid and reversible regulation of collagen XII expression by changes in tensile stress. Exp Cell Res 1999; 247:320-328.
23. Schenk S, Muser J, Vollmer G, Chiquet-Ehrismann R. Tenascin-C in serum: a questionable tumor marker. Int J Cancer 1995; 61:443-449.
24. Seymour GJ, Gemmell E, Reinhardt RA, Eastcott J, Taubman MA. Immunopathogenesis of chronic inflammatory periodontal disease: cellular and molecular mechanisms. J Periodontal Res 1993; 28:478-486.
25. Tonetti MS, Gerber L, Lang NP. Vascular adhesion molecules and initial development of inflammation in clinically healthy human keratinized mucosa around teeth and osseointegrated implants. J Periodontal Res 1994; 29:386-392.
26. Abrahamsson I, Berglundh T, Glantz PO, Lindhe J. The mucosal attachment at different abutments. An experimental study in dogs. J Clin Periodontol 1998; 25:721-727.
27. Koka S. The implant-mucosal interface and its role in the long-term success of endosseous oral implants: a review of the literature. Int J Prosthodont 1998; 11:421-432.
28. Mäkelä M, Salo T, Uitto VJ, Larjava H. Matrix metalloproteinases (MMP-2 and MMP-9) of the oral cavity: cellular origin and relationship to periodontal status. J Dent Res 1994; 73:1397-1406.
29. Maeso G, Bravo M, Bascones A. Levels of metalloproteinase-2 and -9 and tissue inhibitor of matrix metalloproteinase-1 in gingival crevicular fluid of patients with periodontitis, gingivitis, and healthy gingiva. Quintessence Int 2007; 38:247-252.
30. Rai B, Kharb S, Jain R, Anand SC. Biomarkers of periodontitis in oral fluids. J Oral Sci 2008; 50:53-56.
31. Badersten A, Nilvéus R, Egelberg J. Scores of plaque, bleeding, suppuration and probing depth to predict probing attachment loss. 5 years of observation following nonsurgical periodontal therapy. J Clin Periodontol 1990; 17:102-107.
32. Becker W, Becker BE, Newman MG, Nyman S. Clinical and microbiologic findings that may contribute to dental implant failure. Int J Oral Maxillofac Implants 1990; 5:31-38.
33. Renvert S, Persson GR. A systematic review on the use of residual probing depth, bleeding on probing and furcation status following initial periodontal therapy to predict further attachment and tooth loss. J Clin Periodontol 2002; 29 (Suppl 3):82-89.
34. Lang NP, Joss A, Orsanic T, Gusberti FA, Siegrist BE. Bleeding on probing. A predictor for the progression of periodontal disease? J Clin Periodontol 1986; 13:590-596.
35. Esposito M, Hirsch J, Lekholm U, Thomsen P. Differential diagnosis and treatment strategies for biologic complications and failing oral implants: a review of the literature. Int J Oral Maxillofac Implants 1999; 14:473-490.
36. Lang NP, Adler R, Joss A, Nyman S. Absence of bleeding on probing. An indicator of periodontal stability. J Clin Periodontol 1990; 17:714-721.